Evidence map›Paper›PMID 32958529›Full record

ArticleInfection and immunity2020

Neisseria meningitidis Urethritis Outbreak Isolates Express a Novel Factor H Binding Protein Variant That Is a Potential Target of Group B-Directed Meningococcal (MenB) Vaccines.

Yih-Ling Tzeng, Serena Giuntini, Zachary Berman, Soma Sannigrahi, Dan M Granoff, David S Stephens

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Frontiers in immunology · 2024
    Article
  4. Review
  5. Antibiotic Susceptibility Profile for the USOpen forum infectious diseases · 2023
    Article
  6. Infection With the US Neisseria meningitidis Urethritis Clade Does Not Lower Future Risk of Urethral Gonorrhea.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Yih-Ling TzengDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.ORCID 0000-0001-7950-8197
Serena GiuntiniOMVax, Inc., San Francisco, California, USA.
Zachary BermanDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Soma SannigrahiDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA.
Dan M GranoffCenter for Immunobiology and Vaccine Development, University of California San Francisco Benioff Children's Hospital Oakland, Oakland, California, USA.
David S StephensDivision of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia, USA dstep01@emory.edu.
Emory University · USUniversity of California, San Francisco · US

Funding

Novel vaccine strategies for prevention of N. meningitidis group B diseaseR01AI046464 · NIAID · OMVAX, INC. · PI MOE, GREGORY ROBERT · 2000 to 2024
$12.1M
Clinical and molecular epidemiology of the sexual transmission of Neisseria meningitidisR01AI127863 · NIAID · OHIO STATE UNIVERSITY · PI BAZAN, JOSE A., NORRIS TURNER, ABIGAIL · 2017 to 2020
$2.9M
Emergence of ST-11 Neisseria meningitidis as a sexually transmitted pathogenR21AI128313 · NIAID · EMORY UNIVERSITY · PI TZENG, YIH-LING · 2017 to 2018
$429k
NIAID NIH HHS R01 AI046464NIAID NIH HHS R01 AI127863NIAID NIH HHS R21 AI128313Wellcome Trust
6 · The paper itself

Abstract

Factor H binding protein (FHbp) is an important

Indexed as

Amino Acid SequenceAntigens, BacterialAntimicrobial Cationic PeptidesBacterial ProteinsCathelicidinsCell SurvivalComplement Factor HDatabases, GeneticGenomicsHumansMeningitis, MeningococcalMeningococcal InfectionsMeningococcal VaccinesNeisseria meningitidisNeisseria meningitidis, Serogroup BPhylogenyAntigens, BacterialAntimicrobial Cationic PeptidesBacterial ProteinsCathelicidinsCFH protein, humanComplement Factor Hfactor H-binding protein, Neisseria meningitidisMeningococcal Vaccinesfactor Hfactor H binding proteinFHbpNeisseria meningitidisurethritis

Identifiers

PMID32958529
PMCPMC7671903
OpenAlexW3087184763

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.